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ABSTRACT
This study involves a 49-year-old male, who for three years suffered with a 
myelodysplastic syndrome and who needed frequent blood transfusions. One day following 
a transfusion, he presented fever and abdominal pain. The fever became persistent and 
only improved temporarily with two cycles of intravenous ciprofloxacin. Nearly 120 
days after beginning the second cycle of treatment, he had experienced a weight loss 
of 16 kg and recurring fever. Screening for fever of unknown origin was conducted, 
including Bartonella infection. No etiology could be found. The patient improved with 
an antimicrobial regimen composed of oral doxycycline and intravenous ciprofloxacin. 
After 15 days afebrile, the patient was discharged with a four-month oral prescription of 
doxycycline and ciprofloxacin. Eight months following the antibiotic treatment, the patient 
received an allogeneic bone marrow transplant. Five days following the transplant, the 
patient initiated a febrile neutropenia and died. From a blood sample collected and stored 
at the time of hospitalization, a microbiological and molecular study was performed again. 
Blood- and liquid culture-PCRs from the same blood sample were all negative, but an 
isolate from solid subculture was found. The molecular reactions from this isolate were 
all positive and the sequence was 100% homologous to Bartonella henselae. The present 
report points to the limitations of laboratory techniques currently available for investigation 
of possible cases of bartonellosis in clinical practice, and the potential risk of Bartonella 
spp. transmission through blood transfusions.
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Bartonella spp. are Gram-negative, facultative intracellular bacteria. They are 
known to infect erythrocytes and endothelial cells, causing chronic and cyclic 
bacteremia in their hosts. The clinical spectrum of bartonellosis has increased rapidly 
and infection by these bacteria appears to be much more prevalent than diagnosed1.
Although there is no laboratory diagnosis with 100% of sensitivity and 
specificity, the greatest limitation to bartonellosis diagnosis is that most physicians 
do not consider this hypothesis. Any patient with a history of unknown etiology 
of prolonged fever, recurrent or severe anemia, febrile maculopapular rash, 
hepatitis or chronic lymph node disease should include the differential diagnosis 
of bartonellosis2,3. 
This report describes a man with myelodysplastic syndrome who experienced 
fever and abdominal pain following a blood transfusion. Bartonellosis was confirmed 
after isolation of bacteria in solid microbiological culture. 
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A 49-year-old male electrical engineering technician 
born in Belem, PA (01°27’21” S 48°30’16” W) and 
living in Porto Velho, RO (8°45’42” S 63°54’14” W), 
Brazil, was referred to the Hematology Division of 
the University of Campinas (UNICAMP) Hospital, 
Campinas, SP (22°54’25.5744’’ S 47°3’47.6640’’ W) due 
to pancytopenia. He reported having undergone aortic 
valve replacement, pulmonary valve graft, and definitive 
pacemaker implantation by total atrioventricular block 
seven years earlier. He did not provide details of his 
medical conditions but denied having had fever at that 
time. Three years prior to this exam, thrombocytopenia had 
been detected in a routine blood count (81,000 cells/mm3 
of blood), with no hemorrhagic manifestations. His 
condition was accompanied regularly in Porto Velho. 
During this period he developed pancytopenia, and 
underwent transfusions of red blood cells every 15 to 
30 days. He denied smoking, alcoholism and the use of illicit 
drugs. He reported contact with dogs and denied contact 
with cats. After evaluation at the Hematology Division, 
the initial hypothesis of myelodysplastic syndrome was 
confirmed by a bone marrow biopsy. 
Eight months after the diagnosis, the patient needed 
another transfusion of red blood cell concentrate, which was 
performed in another hospital. The day after the transfusion 
procedure, the patient had an episode of fever, abdominal 
pain and vomiting. The febrile condition persisted for 
approximately ten days and, after a transient improvement, 
he again presented persistent fever associated with 
hypogastric colic, but without changes in bowel and urinary 
habits or respiratory complaints. The patient was then 
admitted to the same hospital in which he had undergone 
the last transfusion procedure to investigate the febrile 
condition. Blood cultures collected during hospitalization 
were negative. However, abdominal computed tomography 
revealed a high level of renal discharge, suggesting a renal 
infection, in spite of a negative urine culture. Nevertheless, 
a pyelonephritis diagnostic hypothesis was considered 
without microbiological confirmation, and an antimicrobial 
fourteen-day treatment with parenteral ciprofloxacin was 
started.
Soon after discharge, the patient was hospitalized again 
due to fever of unknown origin (FUO). Examinations 
included transesophageal echocardiography (which did 
not show signs of valvular vegetation), a gastrointestinal 
endoscopy and a colonoscopy (which also showed no 
alterations). He was treated with a new 14-day course of 
parenteral ciprofloxacin. He evolved afebrile and remained 
so for 35 days.
Four months after the onset of fever, the patient returned 
to the Hematology Division at UNICAMP Hospital 
seeking medical attention, for a five-day fever. The fever 
was persistent, with temperatures reaching 40 °C at night, 
accompanied by a drop in his general condition. He reported 
chills, sweating and low back pain. He had lost 16 kg since 
the initial febrile condition five months earlier. He did not 
present respiratory or urinary complaints. Upon physical 
examination, with the exception of anemia and a panfocal 
cardiac murmur related to the valve replacement, there 
were no other changes or clinical signs. Laboratory results 
presented hematuria with erythrocytic dismorphysm, in 
addition to pancytopenia. The patient was hospitalized at 
the UNICAMP Hospital for a new FUO investigation with 
hypotheses of bacterial endocarditis, renal tuberculosis, 
malaria, salmonellosis, visceral leishmaniasis, brucellosis 
and bartonellosis.
In the laboratory investigation, serological exams 
for hepatitis B and C, HIV, syphilis, toxoplasmosis, 
Epstein-Barr virus, cytomegalovirus, Chagas’ disease, 
schistosomiasis, brucellosis, coxiellosis and bartonellosis 
showed no evidence of acute or recent infections. There 
were no parasites in peripheral blood smears. Ten blood 
cultures and three urine cultures, conventional and specific 
for mycobacteria and for fungi were performed. All results 
were negative. Direct searches and cultures of the bone 
marrow aspirates were negative for leishmania, fungi and 
mycobacteria. In order to detect a possible Bartonella sp. 
infection, conventional PCR was performed for the ITS 
region4 and nested PCR was performed for the ftsZ gene5 
from a blood sample whose DNA was extracted using a 
QIAamp DNA minikit (Qiagen Inc., USA), and the results 
were also negative. Full-body scintigraphy using gallium 
showed hypo captive lesions in both kidneys which, 
in association with glomerular hematuria and a febrile 
consumption syndrome, reinforced the hypothesis of renal 
tuberculosis. However, a renal biopsy showed negative 
culture for mycobacteria and a non-specific histology. 
After fourteen days of hospitalization, without diagnosis 
and considering the previous contact with dogs, an 
antimicrobial regimen was initiated with oral doxycycline 
and intravenous ciprofloxacin. The patient remained febrile 
for four days, after which the antimicrobial regimen was 
changed to piperacillin/sulbactam and vancomycin. No 
fever appeared the following day, but after five days he had 
higher daily fever spikes again. One week later, doxycycline 
and ciprofloxacin were reintroduced, given that the patient 
became afebrile less than 24 h after the change of the 
antimicrobial regimen. After being afebrile for fifteen 
days, the patient was discharged with a prescription of 
doxycycline and ciprofloxacin. He remained asymptomatic 
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for two months after which he experienced a five-day fever 
episode at home, in spite of having no change in the use 
of antibiotics. There followed a spontaneous improvement 
of fever and the antibiotics were suspended four months 
after discharge.
Eight months later, without antibiotics, the patient 
was submitted to an allogeneic full match bone marrow 
transplantation (the donor being his sister), due to the 
underlying disease. Five days after transplantation, the 
patient initiated a febrile neutropenia, and an empiric 
treatment with piperacillin/sulbactam, vancomycin and 
metronidazole was initiated. At the time, blood and urine 
cultures were collected and they were all negative. However, 
the patient remained febrile even during antibiotic therapy. 
Ten days after transplantation, he developed a septic shock, 
followed by death. Figure 1 synthesizes the patient’s 
medical history.
Thereafter, a liquid culture was performed using a blood 
sample collected and stored during the hospitalization 
that preceded the transplantation, and during which the 
diagnostic hypothesis of bartonellosis was considered. The 
hypothesis was based on epidemiological contact with dogs 
and the differential diagnosis of FUO. The liquid medium 
was based on Maggi et al.6 and implemented as follows: 900 
mL of IPL-41 medium (insect medium), 0.1 mg of NAD 
(nicotinamide adenine dinucleotide), 1.25 mg of NADP 
(nicotinamide adenine dinucleotide phosphate), 2 mg of 
ATP (adenosine triphosphate), 2 mg of pyruvate and 2 g of 
yeast extract. Two milliliters of whole blood (collected in 
EDTA tube) were introduced into 8 mL of liquid medium. 
Liquid cultures were maintained under constant agitation 
at 35 °C with 5% CO2 for 14 d. Then a subculture was 
sown in solid medium3 and incubated at 35 °C with 5% 
CO2. New molecular reactions (conventional PCRs for the 
ITS region, ssrA gene and nested PCR for the ftsZ gene) 
were performed using the stored whole blood sample, and 
DNA from the liquid culture, extracted using a QIAamp 
DNA minikit (Qiagen Inc., USA). Table 1 shows the 
primer sequences used. All PCRs were negative, but there 
was a microorganism isolated in the solid medium. The 
conventional PCRs for the ITS region, ssrA7 and nested 
PCR for the ftsZ5 from the solid culture isolate were positive. 
The amplicon from the nested PCR was sequenced and 
was 100% homologous to Bartonella henselae Houston-I 
(access number HG965802.1). Table 2 summarizes the 
results obtained. All negative controls from each step of 
the PCR process (DNA extraction, culture and master mix) 
remained negative.
Figure 1 - Timeline illustrating the patient’s medical history.
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DISCUSSION
Bartonella henselae was the only microorganism 
identified during the entire investigation process of FUO, 
suggesting that bartonellosis was probably the cause of 
the febrile illness and, possibly, of the evolution to sepsis.
It is noteworthy that B. henselae was isolated from a 
blood sample even after two 14-day cycles of parenteral 
ciprofloxacin. The patient also had a five-day (quintana) 
fever even after the use of ampicillin / sulbactam and 
vancomycin for one week and the use of oral doxycycline 
and ciprofloxacin for two months. Apparently the agent 
had not been eradicated. In Carrion’s disease, 5% of 
patients treated for Oroya fever develop verruga peruana 
(Peruvian wart) and bacterial clumps can be observed 
in cutaneous lesions, despite adequate treatment and 
improvement of fever. In this infection, antibiotic treatment 
can improve the course of the clinical manifestation, but it 
may not necessarily promote the eradication of Bartonella 
bacilliformis8,9. In addition, there is no consensus about 
the best treatment for chronic and systemic infection by 
B. henselae. In cases of endocarditis there is indication of 
the association of intravenous gentamicin (14 days) and 
oral doxycycline (42 days)8,10.
A possible persistence of infection could not be ruled 
out, since in none of the antimicrobial regimens, the 
association of the recommended drug and the minimum 
duration proposed were followed.
In addition to demonstrating the possible prolonged 
persistence of B. henselae even after the use of successive 
antimicrobial regimens, we observed the limitation of 
the sensitivity of several diagnostic methods available, 
suggesting that non-reactive serological tests and negative-
cultures or negative-molecular assays do not allow to rule 
out the Bartonella sp. infection diagnosis.
In a study with blood donors, it was not possible to 
demonstrate the association between positive serological 
tests (indirect immunofluorescence) and Bartonella sp. 
DNA detection of in blood samples11. This may explain 
the patient negative serology and the positive molecular 
test. In the same study with asymptomatic donors it was 
possible to isolate colonies of B. henselae in six donors. In 
five cases, the molecular tests using a liquid enrichment 
culture sample were negative. The serology of just one of 
the six bacteremic donors tested positive for B. henselae 
and Bartonella quintana antibodies11.
Although we were not able to prove a transfusional 
Bartonella sp. infection, it seems quite plausible that the 
patient described here was infected during one of the many 
transfusion procedures, based on the significant temporal 
relationship between one of the transfusions and the onset 
of the febrile illness. In addition, B. henselae was the only 
Table 1 - PCR primers used in the molecular investigation of the patient with a final diagnosis of bartonelosis.
Primer Nucleotide sequence (5’ – 3’) Molecular target Reference
ITS F CTTCAGATGATGATCCCAAGCCTTYTGGCG
16S-23S rRNA spacer 4
ITS R GAACCGACGACCCCCTGCTTGCAAAGCA
BHF GCCGCAAAGTTCTTTTCATG
ftsZ 5
BHR AGGTGAACGCGCTTGTATTTG
BHS CAAAACGGTTGGAGAGCGT
BHA CGCCTGTCATCTCATCAAGA
ssrA F GCTATGGTAATAAATGGACAATGAAATAA
tmRNA 7
ssrA R GCTTCTGTTGCCAGGTG
Table 2 - Post mortem diagnosis of Bartonella henselae infection through PCR of samples from a 49-year-old male patient with 
myelodysplastic syndrome.
PCR assay
DNA Sample
Blood Liquid Culture Solid Culture
Conventional PCR (ITS) Negative Negative Positive
Nested-PCR (ftsZ) Negative Negative Positive
Conventional PCR (ssrA) NP NP Positive
Final Result Negative Negative Positive
NP: Not Performed
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microorganism identified after an extensive laboratory 
investigation. B. henselae has already been considered a 
pathogen with risk of transmission by transfusion12 after 
blood transfusion experimental infections13.
In summary, the present case report points to: 1) a 
possible association of infection by Bartonella spp.; 2) the 
potential inefficiency of different antimicrobial regimens to 
eradicate Bartonella spp.; 3) the limitations of laboratory 
techniques currently available in clinical practice for the 
investigation of possible cases of bartonellosis; 4) the 
potential risk of transmission of Bartonella spp. by the 
transfusional route; 5) the need for greater attention for 
pathogens such as Bartonella spp. in the investigation 
of febrile post-transfusional procedures; 6) the need to 
improve the screening protocols in blood donations to cover 
pathogens not currently investigated in a usual way. 
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